Search Videos and More
Video
The Role of Locoregional and Systemic Therapies in the Management of Colorectal Liver Metastases
In this video, Dr. Castellanos explains the role of surgical resection in the management of liver-confined metastatic colorectal cancer and using hepatic artery infusion pump (HAIP) chemotherapy for treating resectable and unresectable colorectal liver metastases.
News
Nothing is lost in translation for Russian-speaking patients with urologic cancers
“Even when I was four, I wanted to be a clinician; I’d sit with my grandpa, listen to his ailments, and write prescriptions for him in Russian,” says Elena Dreyzin, PA-C., an advanced practice provider in the Fox Chase Cancer Center Department of Urology.
News
Study Investigates Hypomethylation Immunotherapy Combination in Bladder Cancer
Why does immunotherapy work for some bladder cancer patients and fail for others?
News
A One-Stop Shop for Liver Cancer
Fox Chase Improves Treatment and Access to It
News
Fox Chase Cancer Center Study Challenges Assumptions About Cystic Renal Masses
A Fox Chase study ends up on the cover Journal of Urology cover by revealing a hidden danger in cystic renal masses.
News
Residency & Fellowship. . . to Leadership
Why do many GI Fox Chase Fellow and Residents stay at Fox Chase after training? Hear what a few say about starting and staying here because of the exceptional clinical, research, and leadership opportunities.
News
The World is Dr. Perkins’ Patient
Julia Perkins Smith, MD, Oncology Global Clinical Lead at Pfizer, is a hematologist-oncologist, strategist, and solution seeker -- at the helm of developing breakthrough therapies for breast cancer patients worldwide and implementing clinical trials to examine their efficacy and safety.
Symposium
New Directions in the Diagnosis and Treatment of Hematologic Cancers: Highlights from International Medical Meetings
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, these enduring materials review cutting-edge updates and perspectives on new diagnostic tools and management options of hematologic malignancies. Courses include genetic profiling, cytogenetics, molecular diagnostics, risk adaptive strategies, and novel therapies recently approved by the FDA.
Video
Robotic Prostatectomy
Daniel Eun, MD, Fox Chase-Temple Urologic Institute Provider, discusses the potential benefits of robotic and minimally invasive surgery, and explains his goals for patients following robotic prostatectomy, including maintaining continence and sexual function.
Video
Quality of Life Issues After Prostate Cancer
Michael Metro, MD, Fox Chase-Temple Urologic Institute Provider, discusses different interventions that can improve quality of life issues – such as erectile dysfunction and urinary incontinence -- for patients following prostate cancer surgery.
Video
Robotic Nephrectomy
Daniel Eun, MD, Chief of Robotic Surgery at Temple University Hospital and Fox Chase-Temple Urologic Institute leader, discusses the different kidney sparing robotic and minimally invasive procedures available at Temple, and the potential benefits of these procedures as it relates to maintaining kidney function.
News
Temple Health Launches New Fox Chase-Temple Urologic Institute
Fox Chase Cancer Center and Temple Health are pleased to announce the new Fox Chase-Temple Urologic Institute, a groundbreaking initiative that will concentrate on both benign and oncologic urology.